Khazal, S., Polishchuk, V., Manwani, D., Gallagher, P. G., Prinzing, S., & Mahadeo, K. M. (2016). Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency. Blood, 128(5), 735–737. https://doi.org/10.1182/blood-2016-03-702860

Khazal, Sajad, Veronika Polishchuk, Deepa Manwani, Patrick G. Gallagher, Samantha Prinzing, and Kris Michael Mahadeo. “Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency.” Blood 128, no. 5 (August 4, 2016): 735–37. https://doi.org/10.1182/blood-2016-03-702860.

Khazal S, Polishchuk V, Manwani D, Gallagher PG, Prinzing S, Mahadeo KM. Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency. Blood. 2016 Aug 4;128(5):735–7.

Khazal, Sajad, et al. “Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency.” Blood, vol. 128, no. 5, Aug. 2016, pp. 735–37. Pubmed, doi:10.1182/blood-2016-03-702860.

Khazal S, Polishchuk V, Manwani D, Gallagher PG, Prinzing S, Mahadeo KM. Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency. Blood. 2016 Aug 4;128(5):735–737.